Comparative analysis of novel cholesterol-lowering therapeutics versus statins

The article evaluates the efficacy, clinical utility, and cost-benefit profile of new cholesterol-lowering medications relative to traditional statin therapy. It addresses patient suitability and economic barriers to adoption, though it does not provide specific clinical trial data or regulatory status updates.